# AIRS Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/airs-medical

- Industry: Software
- Headquarters: Seoul, South Korea
- Website: www.airsmed.com
- Total disclosed funding: $61M
- Latest round: Series D (Sep 4, 2026)
- Investors on record: 12

## About

Based in Seoul, South Korea and founded in 2018, AIRS Medical, Inc. provides AI-powered MRI software solutions for the healthcare and radiology industry. The company develops deep learning-based technologies that improve MRI imaging speed, quality, and diagnostic workflows globally. AIRS Medical has expanded internationally, serving institutions across more than 40 countries. In September 2026, AIRS Medical, Inc. raised KRW 30 billion in series D funding from returning investors BSK Investment, Dunamu & Partners, Q Capital Partners, and Samho Green Investment. As of September 2026, the company is led by its CEO, Jason Park, with co-founder Dr. Hyeseong Lee serving as Chairman.

The company works with hospitals, imaging centers, and radiology providers to deliver AI-powered MRI software solutions that improve imaging efficiency and clinical workflows. Its flagship product, SwiftMR, uses deep learning to accelerate MRI scan times while enhancing image quality without requiring hardware upgrades. Additionally, SwiftSight provides MRI quantification and structured reporting tools that assist clinicians in diagnosis and analysis. AIRS Medical’s offerings are built by teams of AI engineers, data scientists, and medical imaging specialists, enabling healthcare providers to optimize scanner utilization, reduce patient wait times, and improve diagnostic accuracy across global healthcare systems.

The company’s revenue is generated by providing enterprise software solutions to healthcare institutions through licensing and subscription-based agreements. Hospitals and imaging centers license AIRS Medical’s AI-powered MRI software platforms, integrating them into existing imaging systems to enhance performance. The company also generates revenue through long-term contracts, software deployment, maintenance, and support services. These solutions are typically sold via direct enterprise sales, partnerships with healthcare providers, and collaborations with medical imaging system stakeholders.

The company plans to use the September 2026 funding to speed up its public listing.

## Funding rounds

- Series D, Sep 4, 2026, $22M — Q Capital Partners, Samho Green Investment, BSK Investment, Dunamu & Partners
- Series C, Jul 10, 2024, $20M — Samho Green Investment, Premier Partners, Dunamu & Partners, BSK Investment, Hana Ventures, Klim Ventures, Shinyoung Securities, GS Ventures
- Series B, Jul 27, 2022, $19M — Q Capital Partners, Hanwha Life Insurance, Klim Ventures
- Series A, Dec 13, 2019 — Spring Camp
- Seed, Feb 1, 2019 — Spring Camp, Korea Tech Incubator for Startup

## Investors

- Spring Camp (https://capitalatlas.ai/funds/spring-camp) — Seed, Series A
- Korea Tech Incubator for Startup — Seed
- Q Capital Partners (https://capitalatlas.ai/funds/q-capital-partners) — Series B, Series D
- Hanwha Life Insurance — Series B
- Klim Ventures (https://capitalatlas.ai/funds/klim-ventures) — Series B, Series C
- Samho Green Investment (https://capitalatlas.ai/funds/samho-green-investment) — Series C, Series D
- Premier Partners (https://capitalatlas.ai/funds/premier-partners) — Series C
- Dunamu & Partners (https://capitalatlas.ai/funds/dunamu-partners) — Series C, Series D
- BSK Investment (https://capitalatlas.ai/funds/bsk-investment) — Series C, Series D
- Hana Ventures — Series C
- Shinyoung Securities (https://capitalatlas.ai/funds/shinyoung-securities) — Series C
- GS Ventures (https://capitalatlas.ai/funds/gs-ventures) — Series C